R. S. P. Rasyid, K. Murti, and Z. Hafy, “The Expression of NFATc1 is more Predominant in Triple Negative Breast Carcinoma Patients”, JKK, vol. 9, no. 1, pp. 43–52, Jan. 2022, doi: 10.32539/jkk.v9i1.193.